Rights and permissions
About this article
Cite this article
US Aredia and Zometa labelling change: osteonecrosis risk. Inpharma Wkly. 1458, 16 (2004). https://doi.org/10.2165/00128413-200414580-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414580-00038